Advertisement
Screener

ASTROTECH Corp (ASTC) Scorecard

ASTROTECH Corp (ASTC) Scorecard

  • 2026-Q2: Total return Win; Revenue growth No data; EPS growth No data.
  • 2026-Q1: Total return Win; Revenue growth Win; EPS growth No data.
  • 2025-Q4: Total return Lose; Revenue growth Win; EPS growth No data.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth No data.
32/79 2.0 / 5 stars All 79 Win/Lose results and 41 gray no-data contests shown below

Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.

Trailing 1 year (4 quarters): 4 wins, 3 losses, 5 no dataLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/1 WinASTC / S&P
108.60% / 15.20%
No dataASTC / S&P
/ 15.00%
No dataASTC / S&P
/ 50.40%
2026-Q12/2 WinASTC / S&P
51.16% / -4.33%
WinASTC / S&P
11.63% / 11.30%
No dataASTC / S&P
/ 27.70%
2025-Q41/2 LoseASTC / S&P
-29.39% / 2.65%
WinASTC / S&P
186.16% / 9.00%
No dataASTC / S&P
/ 13.40%
2025-Q30/2 LoseASTC / S&P
-15.22% / 8.12%
LoseASTC / S&P
3.06% / 4.61%
No dataASTC / S&P
/ 13.45%
2025-Q20/2 LoseASTC / S&P
-10.80% / 10.94%
LoseASTC / S&P
-36.96% / 4.83%
No dataASTC / S&P
/ 10.63%
2025-Q11/2 WinASTC / S&P
-3.57% / -4.27%
LoseASTC / S&P
-54.94% / 4.98%
No dataASTC / S&P
/ 10.57%
2024-Q40/2 LoseASTC / S&P
-15.89% / 2.41%
LoseASTC / S&P
-78.93% / 5.25%
No dataASTC / S&P
/ 6.15%
2024-Q31/2 LoseASTC / S&P
-10.22% / 5.89%
WinASTC / S&P
11.96% / 5.89%
No dataASTC / S&P
/ 6.11%
2024-Q21/2 LoseASTC / S&P
-0.56% / 4.28%
WinASTC / S&P
121.87% / 5.38%
No dataASTC / S&P
/ 5.12%
2024-Q11/2 LoseASTC / S&P
5.42% / 10.56%
WinASTC / S&P
456.67% / 5.71%
No dataASTC / S&P
/ 5.59%
2023-Q41/2 LoseASTC / S&P
-15.94% / 11.69%
WinASTC / S&P
371.33% / 6.81%
No dataASTC / S&P
/ 7.78%
2023-Q31/2 LoseASTC / S&P
-28.67% / -3.27%
WinASTC / S&P
57.92% / 7.52%
No dataASTC / S&P
/ -5.03%
2023-Q21/2 WinASTC / S&P
32.83% / 8.74%
LoseASTC / S&P
-13.69% / 9.50%
No dataASTC / S&P
/ -8.57%
2023-Q10/2 LoseASTC / S&P
6.71% / 7.50%
LoseASTC / S&P
-57.89% / 10.77%
No dataASTC / S&P
/ -15.69%
2022-Q40/2 LoseASTC / S&P
-24.32% / 7.56%
LoseASTC / S&P
-48.03% / 11.88%
No dataASTC / S&P
/ -17.99%
2022-Q32/2 WinASTC / S&P
2.33% / -4.88%
WinASTC / S&P
88.98% / 13.47%
No dataASTC / S&P
/ -1.41%
2022-Q21/2 LoseASTC / S&P
-40.28% / -16.10%
WinASTC / S&P
164.94% / 13.71%
No dataASTC / S&P
/ 11.04%
2022-Q12/2 WinASTC / S&P
5.88% / -4.60%
WinASTC / S&P
77.39% / 15.97%
No dataASTC / S&P
/ 42.23%
2021-Q41/2 LoseASTC / S&P
-35.24% / 11.03%
WinASTC / S&P
48.72% / 15.00%
No dataASTC / S&P
/ 96.40%
2021-Q30/2 LoseASTC / S&P
-21.05% / 0.58%
LoseASTC / S&P
-38.65% / 10.77%
No dataASTC / S&P
/ 69.42%
2021-Q20/2 LoseASTC / S&P
-39.27% / 8.55%
LoseASTC / S&P
-32.79% / 6.58%
No dataASTC / S&P
/ 51.81%
2021-Q12/2 WinASTC / S&P
23.73% / 6.17%
WinASTC / S&P
17.27% / -1.06%
No dataASTC / S&P
/ 7.39%
2020-Q41/2 LoseASTC / S&P
4.12% / 12.15%
WinASTC / S&P
86.35% / -3.72%
No dataASTC / S&P
/ -33.42%
2020-Q31/2 LoseASTC / S&P
-40.35% / 8.93%
WinASTC / S&P
553.68% / -2.04%
No dataASTC / S&P
/ -27.10%
2020-Q21/2 LoseASTC / S&P
9.62% / 20.54%
WinASTC / S&P
284.25% / -0.46%
No dataASTC / S&P
/ -27.11%
2020-Q12/2 WinASTC / S&P
44.44% / -19.60%
WinASTC / S&P
383.53% / 3.47%
No dataASTC / S&P
/ -14.75%
2019-Q41/2 LoseASTC / S&P
1.69% / 9.07%
WinASTC / S&P
244.71% / 5.36%
No dataASTC / S&P
/ 2.99%
2019-Q30/2 LoseASTC / S&P
-29.20% / 1.70%
LoseASTC / S&P
-20.17% / 5.02%
No dataASTC / S&P
/ 0.21%
2019-Q21/2 LoseASTC / S&P
-31.32% / 4.30%
WinASTC / S&P
47.67% / 6.64%
No dataASTC / S&P
/ 8.65%
2019-Q10/2 LoseASTC / S&P
-23.69% / 13.65%
LoseASTC / S&P
-80.32% / 8.12%
No dataASTC / S&P
/ 14.29%
2018-Q41/2 WinASTC / S&P
72.20% / -13.52%
LoseASTC / S&P
-89.92% / 9.05%
No dataASTC / S&P
/ 18.23%
2018-Q30/2 LoseASTC / S&P
-10.65% / 7.71%
LoseASTC / S&P
-91.00% / 10.21%
No dataASTC / S&P
/ 19.06%
2018-Q21/2 WinASTC / S&P
16.98% / 3.43%
LoseASTC / S&P
-96.31% / 9.03%
No dataASTC / S&P
/ 14.46%
2018-Q10/2 LoseASTC / S&P
-20.90% / -0.76%
LoseASTC / S&P
-87.60% / 7.68%
No dataASTC / S&P
/ 12.46%
2017-Q40/2 LoseASTC / S&P
-32.32% / 6.64%
LoseASTC / S&P
-74.22% / 7.03%
No dataASTC / S&P
/ 13.82%
2017-Q31/2 WinASTC / S&P
8.79% / 4.48%
LoseASTC / S&P
-64.05% / 5.68%
No dataASTC / S&P
/ 17.57%
2017-Q20/2 LoseASTC / S&P
-30.53% / 3.09%
LoseASTC / S&P
-12.84% / 4.83%
No dataASTC / S&P
/ 17.74%
2017-Q11/2 LoseASTC / S&P
-12.67% / 6.07%
WinASTC / S&P
168.08% / 3.67%
No dataASTC / S&P
/ 13.32%
2016-Q41/2 LoseASTC / S&P
-9.09% / 3.82%
WinASTC / S&P
193.01% / 2.09%
No dataASTC / S&P
/ 7.05%
2016-Q31/2 LoseASTC / S&P
-2.37% / 3.85%
WinASTC / S&P
1805.18% / 0.20%
No dataASTC / S&P
/ -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricASTC total returnS&P 500 Total Return Index
Total return38.25%20.78%
Annualized return38.25%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricASTC total returnS&P 500 Total Return Index
Total return-78.42%83.14%
Annualized return-26.41%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricASTC total returnS&P 500 Total Return Index
Total return-97.38%319.30%
Annualized return-30.52%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15